Detection with immunohistochemistry [15] showed that slightly more cases with high nuclear expression of STAT3 were observed in the non-GCB DLBCL group and the high expression rates were 12.5% and 32.4% in GCB and non-GCB subtypes, respectively. Here, STAT3 is linked to diffuse large B-cell lymphoma.